LNTH
Lantheus Holdings Inc
$110.31
0.73 (0.67%) Today
— up— down
Market Cap
$7.13B+34.8%
Revenue (TTM)
$1.53B+0.6%
Net Income (TTM)
$269.71M+17.6%
EPS (TTM)
4.14+17.6%
Shares Out
65.11M
65.11MP/E Ratio
24.93
24.93Forward P/E
18.30
18.30Open
$109.80
$109.80Previous Close
$109.58
$109.58Day Range
$109.00 – $111.86
$109.00 – $111.8652-Week Range
$47.25 – $111.86
$47.25 – $111.86Beta
-0.03
-0.03Volume
549.36K
549.36KAvg Volume
1.02M
1.02MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout LNTH
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
Related
News
FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit
Benzinga · 1d ago
Citizens Reiterates Market Outperform on Lantheus Holdings, Maintains $115 Price Target
Benzinga · 1d ago
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
Yahoo · 3d ago
Lantheus Holdings Receives FDA Complete Response Letter For LNTH-2501 Due To Manufacturing Facility Issues; No Safety Or Efficacy Concerns Identified
Benzinga · 4d ago
Healthcare Equipment and Supplies Stocks Q1 Teardown: Lantheus (NASDAQ:LNTH) Vs The Rest
Yahoo · 6d ago